Cape Town - Ascendis [JSE:ASC] has announced on Tuesday the successful completion of a 100% acquisition of Cipla Agrimed SA and Cipla Vet SA.
The value of the agreement is R375m with a potential adjustment to between of R250m and R500m in relation to actual working capital, according to a statement.
Cipla Vet operates in the companion animal segment with sales to over 1 000 outlets and has a strong presence in the South African market, while Cipla Agrimed operates in the commercial animals segment and exports into sub-Saharan Africa.
The acquisitions are a strategic fit for the Phyto-Vet division of Ascendis as it offers a presence in therapeutic areas in which Ascendis did not previously have strong representation, the company said.
Read Fin24's top stories trending on Twitter: Fin24’s top stories